Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
26.52
+0.39 (1.49%)
Aug 28, 2025, 10:37 AM - Market open
Pacira BioSciences Employees
As of December 31, 2024, Pacira BioSciences had 790 total employees, including 788 full-time and 2 part-time employees. The number of employees increased by 78 or 10.96% compared to the previous year.
Employees
790
Change (1Y)
78
Growth (1Y)
10.96%
Revenue / Employee
$893,478
Profits / Employee
-$161,342
Market Cap
1.19B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 790 | 78 | 10.96% |
| Dec 31, 2023 | 712 | -3 | -0.42% |
| Dec 31, 2022 | 715 | 18 | 2.58% |
| Dec 31, 2021 | 697 | 73 | 11.70% |
| Dec 31, 2020 | 624 | 18 | 2.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PCRX News
- 22 days ago - Pacira BioSciences, Inc. (PCRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Pacira BioSciences Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Pacira to Report Second Quarter 2025 Financial Results on Tuesday August 5, 2025 - GlobeNewsWire
- 6 weeks ago - Investors who lost money with shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) should contact the Shareholders Foundation in connection with Lawsuit - PRNewsWire
- 7 weeks ago - Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRX) Shareholders to Inquire about Securities Investigation - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Shareholders to Connect - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRX) Stockholders to Inquire about Securities Investigation - Accesswire